StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX - Free Report) in a report released on Monday. The firm issued a hold rating on the software maker's stock.
Separately, Stephens raised their price objective on Veradigm from $7.00 to $13.00 and gave the company an "equal weight" rating in a research note on Friday, January 31st.
View Our Latest Report on MDRX
Veradigm Stock Performance
MDRX stock remained flat at $4.20 during trading on Monday. 2,943 shares of the company were exchanged, compared to its average volume of 392,666. Veradigm has a 52-week low of $3.80 and a 52-week high of $11.80. The firm's 50-day moving average is $4.39 and its 200 day moving average is $7.07.
About Veradigm
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
See Also
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
